<code id='705E123A2E'></code><style id='705E123A2E'></style>
    • <acronym id='705E123A2E'></acronym>
      <center id='705E123A2E'><center id='705E123A2E'><tfoot id='705E123A2E'></tfoot></center><abbr id='705E123A2E'><dir id='705E123A2E'><tfoot id='705E123A2E'></tfoot><noframes id='705E123A2E'>

    • <optgroup id='705E123A2E'><strike id='705E123A2E'><sup id='705E123A2E'></sup></strike><code id='705E123A2E'></code></optgroup>
        1. <b id='705E123A2E'><label id='705E123A2E'><select id='705E123A2E'><dt id='705E123A2E'><span id='705E123A2E'></span></dt></select></label></b><u id='705E123A2E'></u>
          <i id='705E123A2E'><strike id='705E123A2E'><tt id='705E123A2E'><pre id='705E123A2E'></pre></tt></strike></i>

          Home / explore / hotspot

          hotspot


          hotspot

          author:knowledge    Page View:65
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In